Revolutionizing drug discovery in lung cancer: An artificial intelligence (AI)-assisted framework for identifying target antigens for antibody-drug conjugates. Indian Journal of Biochemistry and Biophysics (IJBB), [S. l.], v. 63, n. 2, p. 137–144, 2026. DOI: 10.56042/ijbb.v63i2.22387. Disponível em: https://or.niscpr.res.in/index.php/IJBB/article/view/22387. Acesso em: 14 may. 2026.